Pneumokokkvaksine bør tilbys alle personer som er 65 år og eldre
Pneumokokkvaksinen kan gjerne gis samtidig som influensavaksine, men forskjellig injeksjonssted må brukes
Pneumokokkvaksinering bør gjentas etter ti år hos eldre. Antistoffmåling er da unødvendig
- 1.
Høiby EA, Aaberge IS, Frøholm LO et al. Utvidet bruk av pneumokokkvaksine i Norge. Oslo: Statens institutt for folkehelse, 1996.
- 2.
Pedersen MK, Høiby EA, Frøholm LO et al. Systemic pneumococcal disease in Norway 1995 – 2001: capsular serotypes and antimicrobial resistance. Epidemiol Infect 2004; 132: 167 – 75.
- 3.
Meldingssystem for smittsomme sykdommer (MSIS). Oslo: Nasjonalt folkehelseinstitutt, 2004.
- 4.
Holm AM, Berild D, Ringertz SH et al. Occurrence and clinical presentation of systemic pneumococcal infections in an unselected population in Oslo, Norway, between 1993 – 1997. Eur J Clin Microbiol Infect 2002; 21: 465 – 7.
- 5.
Artz AS, Ershler WB, Longo DL. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev 2003; 16: 308 – 18.
- 6.
Dear K, Holden J, Andrews R et al. Vaccines for preventing pneumococcal infection in adults. The Cochrane Database of Systematic Reviews. Oxford: Update Software, 2003.
- 7.
Koivula I, Stén M, Leinonen M et al. Clinical efficacy of pneumococcal vaccine in the elderly: A randomized, single-blind population-based trial. Am J Med 1997; 103: 281 – 90.
- 8.
Nichol KL, Baken L, Wuorenma J et al. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999; 159: 2437 – 42.
- 9.
Jackson LA, Neuzil KM, Onchee Y et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. New Engl J Med 2003; 348: 1747 – 55.
- 10.
Örtqvist Å, Hedlund J, Burman L-Å et al. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 1998; 351: 399 – 403.
- 11.
Christenson B, Hedlund J, Lundbergh P et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004; 23: 363 – 8.
- 12.
Hedlund J, Christenson B, Lundbergh P et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. Vaccine 2003; 21: 3906 – 11.